Coronavirus Update: Moderna Scales Up Manufacturing, Sosei Looks To Structure-Based Design, Taking Stock Of India’s Lockdown

Moderna details plans on how it will make enough of its coronavirus vaccine, and Sosei is using structure-based design technology to target a SARS-CoV-2 non-strucural protein. Meanwhile, the industry in India faces up to lockdown.   

Microscopic cells of Coronavirus
• Source: Shutterstock

Moderna Inc. provided details about its plans to scale up manufacturing of its COVID-19 vaccine candidate, mRNA-1273, at a 14 April "Vaccines Day" with investors.

CEO Stéphane Bancel said its Norwood, MA, facility is ready to produce millions of doses of the vaccine, and is...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip